TTNP

Titan Pharmaceuticals, Inc. TTNP

TTNP
Titan Pharmaceuticals, Inc. CDIO
Cardio Diagnostics Holdings, Inc. XBIO
Xenetic Biosciences, Inc. ALZN
Alzamend Neuro, Inc. CYCN
Cyclerion Therapeutics, Inc. TCRT
Alaunos Therapeutics, Inc. ADIL
Adial Pharmaceuticals, Inc. XTLB
XTL Biopharmaceuticals Ltd. IBO
Impact BioMedical Inc. NRSN
NeuroSense Therapeutics Ltd.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode TTNP CDIO XBIO ALZN CYCN TCRT ADIL XTLB IBO NRSN
6M 30.32 % -61.41 % 82.16 % -63.07 % -16.04 % 16.10 % -48.05 % 16.81 % 37.64 % 18.45 %
YTD 53.61 % -83.49 % 8.40 % -78.15 % -31.61 % 57.36 % -64.87 % -32.99 % -60.94 % 6.09 %
1Y 1.24 % -36.79 % 18.33 % -84.20 % -10.71 % 28.63 % -63.84 % -33.33 % -58.80 % 24.55 %
3Y -75.00 % -98.59 % -18.40 % -99.85 % -67.86 % -98.20 % -95.35 % 9.09 % -99.85 % -25.61 %
5Y -94.17 % -98.53 % -50.73 % -99.99 % -96.19 % -99.24 % -99.21 % -32.31 % -99.85 % -69.80 %
10Y -99.97 % -98.53 % -99.28 % -99.99 % -99.10 % -99.81 % -99.63 % -85.73 % -97.59 % -69.80 %
Depuis le début -100.00 % -98.53 % -99.28 % -99.99 % -99.10 % -99.87 % -99.63 % -99.77 % -97.59 % -69.80 %

Dividende